WEBINAR: Biomaterials to Create T Cell Immunity

Due to technical difficulties, this webinar was not recorded.

The Society For Biomaterials hosted a webinar on Wednesday, July 15, 2020. Dr. David Mooney presented Biomaterials to Create T Cell Immunity. Cancer immunotherapy can be life-saving, but many cancer patients do not currently benefit. We are creating biomaterials capable of concentrating, interrogating, and manipulating stem and immune cells ex vivo and in the body by controlling, in space and time, the interaction of the cells with various cues and drugs.  The utility of this concept in the development of therapeutic cancer vaccines, adoptive T cell therapies, and T cell reconstitution will be highlighted.

 

About the Presenter:
David Mooney is the Pinkas Family Professor of Bioengineering in the Harvard School of Engineering and Applied Sciences, and a Core Faculty Member of the Wyss Institute. He received his B.S. in Chemical Engineering from the University of Wisconsin, and Ph.D. in Chemical Engineering from MIT.  His laboratory designs biomaterials to make cell and protein therapies effective and practical approaches to treat disease. He is a member of the National Academy of Engineering, the National Academy of Medicine, and the National Academy of Inventors.  He has won numerous awards, including the Clemson Award from the SFB, MERIT award from the NIH, Distinguished Scientist Award from the IADR, Phi Beta Kappa Prize for Excellence in Undergraduate Teaching, and the Everett Mendelsohn Excellence in Mentoring Award from Harvard College.  His inventions have been licensed by over 14 companies, leading to commercialized products.  He has founded two companies and is active on industrial scientific advisory boards.

This webinar is sponsored/hosted by the BioInterfaces SIG. 

SFB News

NOW VIRTUAL! Due to pandemic-related travel restrictions and concerns, we have determined to switch to an all-virtual meeting platform and will work to accommodate all accepted poster and oral presentations on that platform. The abstract deadline...